Title : Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-cis Retinoic Acid in Children with Neuroblastoma: A Randomized Crossover Clinical Trial.

Pub. Date : 2021 Apr 14

PMID : 33919763






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 (1) Background: 13-cis-retinoic acid (13-CRA) is a key component of neuroblastoma treatment protocols. Isotretinoin myotubularin related protein 11 Homo sapiens